ArticleRheumatology international2025
Low vaccination uptake and attitudes towards COVID-19, influenza, and Streptococcus pneumoniae vaccines: a cross-sectional survey of patients with rheumatic diseases.
Article in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with immune-mediated inflammatory diseases (IMIDs) are at increased risk for vaccine-preventable infections (VPIs), yet vaccination uptake remains suboptimal in European countries. This is the first study that assessed vaccination rates, adverse events, and attitudes toward COVID-19, influenza, and S. pneumoniae vaccines among IMID patients in Croatia. We conducted a cross-sectional survey (May–October 2023) using an adapted and translated version of the COVID-Vaccination Attitude Scale (C-VAS) incorporating Health Belief Model (HBM) constructs. Adult IMID patients under rheumatology follow-up for ≥3 years at a tertiary centre were invited to participate. Data were verified against medical records. Descriptive statistics, Chi-square tests, and Mann–Whitney U tests compared vaccination status with sociodemographic variables and HBM constructs. 71 patients (median age 55 years; 73% female) were analysed. Vaccination rates were 69% for COVID-19, 35.2% for influenza, and 16.9% for S. pneumoniae. COVID-19, influenza, and S. pneumoniae infections were reported in 64.8%, 12.7%, and 4.2% of patients, respectively. Influenza vaccination was significantly associated with employment/retirement, age ≥50 years, and prior influenza infection. Vaccination against S. pneumoniae was more frequent in men. Adverse events were uncommon; serious vaccine-related events occurred only after COVID-19 vaccination (n = 2), whereas more severe complications followed infections. Vaccinated patients showed significantly higher perceived benefits, severity, and risk, and lower perceived barriers, across most HBM domains. In this study, uptake od influenza and S. pneumoniae was low among patients with IMIDs despite a favourable safety profile and more severe outcomes from infection than vaccination. Targeted education addressing perceived barriers and improving risk perception may increase vaccine uptake. Further randomized studies in IMID populations are warranted.
Indexed as
Identifiers
41258466What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.